These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 28517656)

  • 1. SU-E-I-78: Neuromelanin in the Subthalamic Nucleus of Patients with Parkinson's Disease: An Electron Spin Resonance Spectroscopy Study.
    Gomez J; Salmon CG; Filho OB; Santos JP; Pitella J
    Med Phys; 2012 Jun; 39(6Part5):3643. PubMed ID: 28517656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of neuromelanin and iron in substantia nigra and other areas of human brain.
    Zecca L; Shima T; Stroppolo A; Goj C; Battiston GA; Gerbasi R; Sarna T; Swartz HM
    Neuroscience; 1996 Jul; 73(2):407-15. PubMed ID: 8783258
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of a synthetic neuromelanin on yield of free hydroxyl radicals generated in model systems.
    Zareba M; Bober A; Korytowski W; Zecca L; Sarna T
    Biochim Biophys Acta; 1995 Jun; 1271(2-3):343-8. PubMed ID: 7605801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Total and paramagnetic metals in human substantia nigra and its neuromelanin.
    Zecca L; Swartz HM
    J Neural Transm Park Dis Dement Sect; 1993; 5(3):203-13. PubMed ID: 8396395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The roles of neuromelanin, binding of metal ions, and oxidative cytotoxicity in the pathogenesis of Parkinson's disease: a hypothesis.
    Enochs WS; Sarna T; Zecca L; Riley PA; Swartz HM
    J Neural Transm Park Dis Dement Sect; 1994; 7(2):83-100. PubMed ID: 7710667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Q-band EPR investigations of neuromelanin in control and Parkinson's disease patients.
    Lopiano L; Chiesa M; Digilio G; Giraudo S; Bergamasco B; Torre E; Fasano M
    Biochim Biophys Acta; 2000 Mar; 1500(3):306-12. PubMed ID: 10699372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Purified human neuromelanin, synthetic dopamine melanin as a potential model pigment, and the normal human substantia nigra: characterization by electron paramagnetic resonance spectroscopy.
    Enochs WS; Nilges MJ; Swartz HM
    J Neurochem; 1993 Jul; 61(1):68-79. PubMed ID: 8390568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuromelanin can protect against iron-mediated oxidative damage in system modeling iron overload of brain aging and Parkinson's disease.
    Zecca L; Casella L; Albertini A; Bellei C; Zucca FA; Engelen M; Zadlo A; Szewczyk G; Zareba M; Sarna T
    J Neurochem; 2008 Aug; 106(4):1866-75. PubMed ID: 18624918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Magnetic investigations of human mesencephalic neuromelanin.
    Bolzoni F; Giraudo S; Lopiano L; Bergamasco B; Fasano M; Crippa PR
    Biochim Biophys Acta; 2002 Mar; 1586(2):210-8. PubMed ID: 11959462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Substantia nigra neuromelanin magnetic resonance imaging in de novo Parkinson's disease patients.
    Reimão S; Pita Lobo P; Neutel D; Correia Guedes L; Coelho M; Rosa MM; Ferreira J; Abreu D; Gonçalves N; Morgado C; Nunes RG; Campos J; Ferreira JJ
    Eur J Neurol; 2015 Mar; 22(3):540-6. PubMed ID: 25534480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fe(3+) ions in alkali lead tetraborate glasses--an electron paramagnetic resonance and optical study.
    Chakradhar RP; Sivaramaiah G; Rao JL; Gopal NO
    Spectrochim Acta A Mol Biomol Spectrosc; 2005 Nov; 62(1-3):51-7. PubMed ID: 16257692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modifications of the iron-neuromelanin system in Parkinson's disease.
    Fasano M; Bergamasco B; Lopiano L
    J Neurochem; 2006 Feb; 96(4):909-16. PubMed ID: 16417570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ESR investigation of sucrose radicals produced by particle irradiation.
    Nakagawa K; Sato Y
    Spectrochim Acta A Mol Biomol Spectrosc; 2004 May; 60(6):1315-8. PubMed ID: 15134729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuromelanin in human dopamine neurons: comparison with peripheral melanins and relevance to Parkinson's disease.
    Fedorow H; Tribl F; Halliday G; Gerlach M; Riederer P; Double KL
    Prog Neurobiol; 2005 Feb; 75(2):109-24. PubMed ID: 15784302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The enigma of neuromelanin in Parkinson's disease substantia nigra.
    Youdim MB; Ben-Shachar D; Riederer P
    J Neural Transm Suppl; 1994; 43():113-22. PubMed ID: 7884393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EPR investigations of the iron domain in neuromelanin.
    Aime S; Bergamasco B; Biglino D; Digilio G; Fasano M; Giamello E; Lopiano L
    Biochim Biophys Acta; 1997 Jul; 1361(1):49-58. PubMed ID: 9247089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Label-Free Nanoimaging of Neuromelanin in the Brain by Soft X-ray Spectromicroscopy.
    Brooks J; Everett J; Lermyte F; Tjhin VT; Banerjee S; O'Connor PB; Morris CM; Sadler PJ; Telling ND; Collingwood JF
    Angew Chem Int Ed Engl; 2020 Jul; 59(29):11984-11991. PubMed ID: 32227670
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of sequestering intrinsic iron on the electron paramagnetic resonance signals in powdered soy proteins.
    Boatright WL; Jahan MS
    J Food Sci; 2013 May; 78(5):C660-6. PubMed ID: 23551223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Current views on the mechanisms of dopaminergic neuron death of the nigrostriatal system in Parkinson's disease].
    Bertrand E; Lechowicz W; Szpak GM; Dymecki J
    Neurol Neurochir Pol; 1997; 31(2):295-302. PubMed ID: 9380259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protective and Damaging Mechanisms of Neuromelanin-Like Nanoparticles and Iron in Parkinson's Disease.
    Liu L; Wang T; Zhou H; Zheng J; Liu Q; Wang W; Liu X; Zhang X; Ge D; Shi W; Sun Y
    Adv Healthc Mater; 2024 Oct; ():e2402718. PubMed ID: 39358952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.